More non-Q-wave myocardial infarctions but similar infarct sizes in patients with hypertension

I Aursnes1, K Landmark

  • 1Department of Pharmnacotherapeutics, University of Oslo, Nornvay. i.a.aursnes@ioks.uio.no

Blood Pressure
|June 16, 2000
PubMed

Insights

Hypertension history in acute myocardial infarction patients did not affect infarct size. However, hypertensive individuals had a 151% increased chance of developing non-Q-wave myocardial infarction.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Myocardial Infarction Studies

Background:

  • Coronary artery disease and acute myocardial infarction (AMI) are significant health concerns.
  • Hypertension is a major risk factor for cardiovascular diseases, including AMI.
  • The impact of pre-existing hypertension on AMI characteristics and outcomes requires further investigation.

Purpose of the Study:

  • To investigate the relationship between a history of hypertension and infarct characteristics in patients admitted for acute myocardial infarction.
  • To determine if hypertension influences infarct size, infarct wave type, and treatment patterns.

Main Methods:

  • Retrospective analysis of 350 consecutive patients admitted with acute myocardial infarction.
  • Comparison of demographic, clinical, and treatment data between hypertensive and normotensive patient groups.
  • Assessment of infarct size using peak enzyme levels and analysis of non-Q-wave infarct development.

Main Results:

  • 31% of AMI patients had a history of hypertension; they were older, more often female, and received less thrombolytic treatment.
  • Hypertensive patients had higher admission blood pressure, particularly males.
  • No significant difference in infarct size was observed between hypertensive and normotensive groups.
  • Hypertension was associated with a 151% increased odds of developing a non-Q-wave myocardial infarction (adjusted odds ratio 2.51, p=0.003).

Conclusions:

  • A history of hypertension does not alter infarct size in acute myocardial infarction.
  • Hypertensive patients exhibit a higher propensity for developing non-Q-wave myocardial infarctions, suggesting differential myocardial necrosis patterns.
  • This propensity may explain the reduced use of fibrinolytic therapy in hypertensive patients with AMI.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...